A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

BACKGROUND: A research priority in finding a cure for HIV is to establish methods to accurately locate and quantify where and how HIV persists in people living with HIV (PLWH) receiving suppressive antiretroviral therapy (ART). Infusing copper-64 ((64)Cu) radiolabelled broadly neutralising antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, James H., Zerbato, Jennifer M., Lau, Jillian S.Y., Lange, Jaclyn L., Roche, Michael, Tumpach, Carolin, Dantanarayana, Ashanti, Rhodes, Ajantha, Chang, Judy, Rasmussen, Thomas A., Mackenzie, Charlene A., Alt, Karen, Hagenauer, Michelle, Roney, Janine, O‘Bryan, Jessica, Carey, Alexandra, McIntyre, Richard, Beech, Paul, O'Keefe, Graeme J., Wichmann, Christian W., Scott, Fiona E., Guo, Nancy, Lee, Sze-Ting, Liu, Zhanqi, Caskey, Marina, Nussenzweig, Michel C., Donnelly, Paul S., Egan, Gary, Hagemeyer, Christoph E., Scott, Andrew M., Lewin, Sharon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921458/
https://www.ncbi.nlm.nih.gov/pubmed/33640794
http://dx.doi.org/10.1016/j.ebiom.2021.103252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921458/
https://www.ncbi.nlm.nih.gov/pubmed/33640794
http://dx.doi.org/10.1016/j.ebiom.2021.103252

Ejemplares similares